The South Centre Monthly, August 2019
The worldwide problem of the rise in antimicrobial resistance (AMR) is a serious threat to global public health. The loss of efficacy of antibiotics and other antimicrobials affects everyone. Yet the threat is greater in developing countries, due to the higher incidence of infectious diseases. Developing countries will be unequivocally affected by AMR, deteriorating the health of the population, reducing economic growth and exacerbating poverty and inequalities. The blueprint for addressing AMR as a global problem is advanced. Countries are progressing in developing and implementing national action plans and overall the public awareness of AMR is increasing.
However, we are at the tip of the iceberg of response. AMR is not yet a key priority of most governments, and global coordination and resource mobilization to enable all countries to do their part are lagging. The Secretary-General of the United Nations (UN) in the upcoming 74th UN General Assembly (UNGA) will be reporting on the implementation of the UN resolution on AMR of 2016, including the recommendations of the Interagency Coordination Group (IACG) on Antimicrobial Resistance. The UNGA will also host a High-Level Meeting to build support for advancing Universal Health Coverage (UHC), that is essential for AMR response. Expanding primary health care services, strengthening the health work force, improving infection prevention and control and measures to secure access to essential medicines and others to reduce health inequities can help contain AMR in developing countries. Developing countries need to be actively involved in shaping the global agenda on antimicrobial resistance, including the new global governance mechanisms that are being set up for AMR.
For the month of August, the South Centre released publications including on Hepatitis C antiviral drugs, the patent system and public health in Colombia; intellectual property and the investor-state dispute settlement system; and the US embargo on Cuba and its human rights impacts. In addition, news were published on, inter alia, an experts’ meeting on climate finance needs of developing countries where South Centre staff participated; a workshop on tuberculosis and innovation supported by the Centre; an information session on AMR, agriculture and sustainable development goals and a regional conference on AMR in the context of UHC in Africa organized by the Centre; and sports, development and human rights.
This South Centre Monthly provides more information on these issues and activities; we will welcome your comments.
This article was tagged: Access to Medicines, Affordable Medicines, Africa, Agriculture, Antimicrobial Resistance (AMR), Antiviral drugs, Climate Change, Climate Financing, Colombia, Competition Law, Cuba, Embargo, Health, Hepatitis C, Human Rights, Innovation, Intellectual Property, Intergovernmental Panel on Climate Change (IPCC), Investor-State Dispute Settlement (ISDS) System, Mexico, Patent, Public Health, South Africa, Sustainable Development Goals (SDGs), Tuberculosis (TB), Unilateral Coercive Measures, United Nations Conference on Trade and Development (UNCTAD), United Nations Framework Convention on Climate Change (UNFCCC), United States (US), Universal Health Coverage (UHC), US-Mexico-Canada Agreement (USMCA)